MH9-18926-09461
3 vaccinations
3 coded responses
8 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 836 / ID
- Registered
- 2021-08-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-26
Dose 2 — Pfizer-BioNTech
-
2021-08-12
Registered in v-safe
- 2021-08-12
- 2021-08-27
-
2021-09-17
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Survey response — day 7, dose 3MedDRA: Pre-eclampsia — Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: symptoms related to preeclampsiaMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-10
-
2021-10-25
Survey response — day 35, dose 3MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: PreeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Report sent to call center — day 35, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2021-10-26
- 2021-10-29
-
2021-12-19
Survey response — 3 months, dose 3MedDRA: Influenza, Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold/fluMedDRA releases: 2024-11 · check-in free text available
-
2021-12-19
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | No |
| 2 | 2021-02-26 | Pfizer-BioNTech | No |
| 3 | 2021-09-17 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 9 — day 7, dose 3
Systemic reaction (other): symptoms related to preeclampsia
Release 10 — day 35, dose 3
Symptoms: Preeclampsia
Release 10 — 3 months, dose 3
Symptoms: Cold/flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Pre-eclampsia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release